| DB00002 | unknown | NA | Cetuximab | approved | DB00005 | unknown | NA | Etanercept | approved|investigational | DB00028 | yes | antagonist | Immune Globulin Human | approved|investigational | DB00051 | unknown | NA | Adalimumab | approved | DB00054 | unknown | NA | Abciximab | approved | DB00056 | unknown | NA | Gemtuzumab ozogamicin | approved|investigational|withdrawn | DB00072 | unknown | NA | Trastuzumab | approved|investigational | DB00073 | unknown | NA | Rituximab | approved | DB00074 | unknown | NA | Basiliximab | approved|investigational | DB00075 | unknown | NA | Muromonab | approved|investigational | DB00078 | unknown | NA | Ibritumomab tiuxetan | approved | DB00081 | unknown | NA | Tositumomab | approved | DB00087 | unknown | NA | Alemtuzumab | approved|investigational | DB00092 | unknown | NA | Alefacept | approved|withdrawn | DB00095 | unknown | NA | Efalizumab | approved|investigational | DB00108 | unknown | NA | Natalizumab | approved|investigational | DB00110 | unknown | NA | Palivizumab | approved|investigational | DB00111 | unknown | NA | Daclizumab | approved|investigational | DB00112 | unknown | NA | Bevacizumab | approved|investigational |